Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms
- 3 May 2020
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 19 (7) , 102572
Abstract
No abstract availableKeywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca
This publication has 35 references indexed in Scilit:
- Emerging roles for platelets as immune and inflammatory cellsBlood, 2014
- Inflammation, obesity, and thrombosisBlood, 2013
- Neutrophils, neutrophil extracellular traps and interleukin-17 associate with the organisation of thrombi in acute myocardial infarctionThrombosis and Haemostasis, 2013
- IL-17A Facilitates Platelet Function through the ERK2 Signaling Pathway in Patients with Acute Coronary SyndromePLOS ONE, 2012
- Combination of IL-17 and TNFα induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cellsAnnals of the Rheumatic Diseases, 2012
- Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2011
- IL-17A increases ADP-induced platelet aggregationBiochemical and Biophysical Research Communications, 2011
- Functional Specialization of Interleukin-17 Family MembersImmunity, 2011
- From IL-15 to IL-33: the never-ending list of new players in inflammation. Is it time to forget the humble aspirin and move ahead?Biochemical Pharmacology, 2010
- Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory DiseaseAnnual Review of Immunology, 2009